Gene therapy for human brain tumors by ectopic overexpression of cell cycle cyclin-dependent kinase inhibitors (CDKIs) • 646

被引:0
|
作者
Jun Chen
Frank Hong
Perry D Nisen
机构
[1] Pediatrics,
[2] UT Southwestern,undefined
关键词
D O I
10.1203/00006450-199704001-00666
中图分类号
学科分类号
摘要
引用
收藏
页码:110 / 110
相关论文
共 50 条
  • [1] CANCER THERAPY BY CYCLIN-DEPENDENT KINASE INHIBITORS (CDKIS): BENCH TO BEDSIDE
    Hassanzadeh, Ali
    Shomali, Navid
    Soltani-Zangbar, Mohammad Sadegh
    Nasiri, Hadi
    Akbari, Morteza
    [J]. EXCLI JOURNAL, 2024, 23 : 862 - 882
  • [2] Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation
    Sielecki, TM
    Boylan, JF
    Benfield, PA
    Trainor, GL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) : 1 - 18
  • [3] Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system - Potential targets for therapy?
    Li, JM
    Brooks, G
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (06) : 406 - 420
  • [4] Cyclin-dependent kinase inhibitors and human cancer
    Kamb, A
    [J]. CYCLIN DEPENDENT KINASE (CDK) INHIBITORS, 1998, 227 : 139 - 148
  • [5] Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors
    Cho, NH
    Kim, YT
    Kim, JW
    [J]. YONSEI MEDICAL JOURNAL, 2002, 43 (06) : 722 - 728
  • [6] Cyclin-dependent kinase inhibitors: A new family of cell cycle regulators.
    Baldin, V
    Goubin, F
    Leroy, D
    Ducommun, B
    [J]. ANNEE BIOLOGIQUE, 1995, 34 (04): : 159 - 174
  • [7] Cyclin-dependent kinase 7 inhibitors in cancer therapy
    Wang, Minmin
    Wang, Tianyu
    Zhang, Xiangyu
    Wu, Xiaoxing
    Jiang, Sheng
    [J]. FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 813 - 833
  • [8] MYC oncogene antagonists and cyclin-dependent kinase inhibitors in the treatment of brain tumors.
    Chen, J
    Bezdek, T
    Chang, J
    Huang, F
    Willingham, T
    Azarra, M
    Nisen, PD
    [J]. CANCER GENE THERAPY, 1996, 3 (06) : P102 - P102
  • [9] Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer
    Amani, Jafar
    Gorjizadeh, Nassim
    Younesi, Simin
    Najafi, Mojtaba
    Ashrafi, Arash M.
    Irian, Saeed
    Gorjizadeh, Negar
    Azizian, Khalil
    [J]. DNA REPAIR, 2021, 102
  • [10] Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2
    Johnson, LN
    De Moliner, E
    Brown, NR
    Song, HW
    Barford, D
    Endicott, JA
    Noble, MEM
    [J]. PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) : 113 - 124